Search by Drug Name or NDC
NDC 51224-0162-24 Astringent 1347; 952 mg/2299mg; mg/2299mg Details
Astringent 1347; 952 mg/2299mg; mg/2299mg
Astringent is a TOPICAL POWDER, FOR SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by TAGI Pharma Inc.. The primary component is ALUMINUM SULFATE TETRADECAHYDRATE; CALCIUM ACETATE MONOHYDRATE.
Product Information
| NDC | 51224-0162 |
|---|---|
| Product ID | 51224-162_4056d8c0-ca3f-4f8c-9fee-af9727a65267 |
| Associated GPIs | 90971002103020 |
| GCN Sequence Number | 068915 |
| GCN Sequence Number Description | calcium acetate/aluminum sulf POWD PACK 952-1347MG TOPICAL |
| HIC3 | Q5A |
| HIC3 Description | TOPICAL PREPARATIONS,MISCELLANEOUS |
| GCN | 31828 |
| HICL Sequence Number | 003055 |
| HICL Sequence Number Description | CALCIUM ACETATE/ALUMINUM SULFATE |
| Brand/Generic | Generic |
| Proprietary Name | Astringent |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Calcium acetate monohydrate and Aluminum sulfate tetradecahydrate |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | POWDER, FOR SOLUTION |
| Route | TOPICAL |
| Active Ingredient Strength | 1347; 952 |
| Active Ingredient Units | mg/2299mg; mg/2299mg |
| Substance Name | ALUMINUM SULFATE TETRADECAHYDRATE; CALCIUM ACETATE MONOHYDRATE |
| Labeler Name | TAGI Pharma Inc. |
| Pharmaceutical Class | Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH NOT FINAL |
| Application Number | part347 |
| Listing Certified Through | n/a |
Package
NDC 51224-0162-24 (51224016224)
| NDC Package Code | 51224-162-24 |
|---|---|
| Billing NDC | 51224016224 |
| Package | 12 BOX in 1 CARTON (51224-162-24) / 12 PACKET in 1 BOX (51224-162-12) / 2299 mg in 1 PACKET (51224-162-99) |
| Marketing Start Date | 2012-06-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |